As one of the leaders and co-founders of Tryptomics, Christopher Pauli's past accomplishments in molecular biology speak for themselves. With a wealth of experience in genomic and transcriptomic analyses, as well as assay development for numerous psychoactive plants and fungi, Christopher has long been recognized as a trailblazer in the industry. One of his most notable contributions has been his groundbreaking work in developing marker-assisted breeding systems, which have enabled breeders to create custom chemical profiles to produce desired medicinal and recreational effects in Cannabis sativa. His outstanding research in secondary metabolite profile prediction and pathogen detection assays has earned him recognition as the lead inventor for three utility patents focused on genetic markers. Christopher's expertise in both Cannabis and fungi has also been instrumental in his development of an intellectual property strategy that has protected, licensed, and further developed technologies related to various aspects of genetic classification and breeding selection. Tryptomics is thrilled to have Christopher on board as part of our leadership team and driving force behind our intellectual property development.